0.7662
Schlusskurs vom Vortag:
$0.6809
Offen:
$0.7552
24-Stunden-Volumen:
38.10M
Relative Volume:
5.87
Marktkapitalisierung:
$8.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.23M
KGV:
-0.6242
EPS:
-1.2274
Netto-Cashflow:
$-10.29M
1W Leistung:
+37.31%
1M Leistung:
+117.36%
6M Leistung:
-53.56%
1J Leistung:
-88.81%
Seastar Medical Holding Corp Stock (ICU) Company Profile
Firmenname
Seastar Medical Holding Corp
Sektor
Branche
Telefon
844-427-8100
Adresse
3513 BRIGHTON BLVD, DENVER
Vergleichen Sie ICU mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ICU
Seastar Medical Holding Corp
|
0.7662 | 12.38M | 0 | -26.23M | -10.29M | -1.2274 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Seastar Medical Holding Corp Aktie (ICU) Neueste Nachrichten
ICU’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
What analysts say about SeaStar Medical Holding Corporation stockHigh-yield portfolio picks - jammulinksnews.com
SeaStar Medical reports positive early results from pediatric AKI therapy By Investing.com - Investing.com South Africa
Breakthrough: 75% of Critical Pediatric Kidney Patients Survive with New QUELIMMUNE Treatment - Stock Titan
How SeaStar Medical Holding Corporation Equity Warrant stock performs during market volatilityFree Professional Portfolio Management - Newser
What makes SeaStar Medical Holding Corporation Equity Warrant stock price move sharplyMoney Making Low Risk Plans - Newser
SeaStar Medical Holding Corporation Equity Warrant Stock Analysis and ForecastMarket-beating performance - jammulinksnews.com
Why SeaStar Medical Holding Corporation Equity Warrant stock is on top investor watchlistsEntry Level Low Risk Picks - Newser
Should I buy SeaStar Medical Holding Corporation stock before earningsEarly Breakout Tracker - Newser
The ICU Stock Puzzle: Unraveling SeaStar Medical Holding Corp’s Fluctuating Performance - investchronicle.com
Leading Children's Hospital Adopts Revolutionary QUELIMMUNE Kidney Therapy as Trial Nears Completion - Stock Titan
How SeaStar Medical Holding Corporation stock performs during market volatilityTop ROI Selections - Newser
Why SeaStar Medical Holding Corporation stock attracts strong analyst attentionProfessional Stock Screener - Newser
What makes SeaStar Medical Holding Corporation stock price move sharplyProven Trading Plan - Newser
SeaStar Medical announces registered direct offering - Medical Buyer
SeaStar Medical raises $4 million in at-market offering By Investing.com - Investing.com South Africa
SeaStar Medical raises $4 million in at-market offering - Investing.com
SeaStar Medical announces $4M registered direct offering - TipRanks
ICU pauses $7.4M ATM, leaves $6.2M unused – dilution on hold | ICU SEC FilingForm 424B5 - Stock Titan
SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI) - Yahoo Finance
SeaStar Medical shareholders approve director elections and equity plan changes - Investing.com Nigeria
SeaStar Medical shareholders approve director elections and equity plan changes By Investing.com - Investing.com South Africa
Revolutionary QUELIMMUNE Treatment Cuts Pediatric AKI Deaths by 50% at Texas Children's Hospital - Stock Titan
Medical Holding Corporation regains Nasdaq compliance By Investing.com - Investing.com Nigeria
SeaStar Medical: Compliance Triumph and Clinical Momentum Signal a Turnaround in Critical Care Innovation - AInvest
SeaStar Medical’s QUELIMMUNE Shows Promise in Treating Pediatric AKI - citybuzz -
SeaStar's QUELIMMUNE Can Cut Pediatric Sepsis Deaths In Half - FinancialContent
SeaStar takes series of transactions to ensure Nasdaq’s compliance - Medical Buyer
US Stocks Mixed; General Mills Shares Fall After Q4 Results - Benzinga
Life-Saving QUELIMMUNE Therapy Success Featured by Cincinnati Children's Hospital | ICU Stock News - Stock Titan
SeaStar Medical Holding Corp Inc. (ICU) Price Performance: A Fundamental Analysis Perspective - investchronicle.com
SeaStar Medical stock plunges after pricing million public offering - Investing.com Australia
SeaStar Medical Announces Pricing of Up to $8 Million Public Offering - The Manila Times
SeaStar Medical (NASDAQ:ICU) Stock Price Up 1% – What’s Next? - Defense World
Short Interest in SeaStar Medical Holding Corporation (NASDAQ:ICU) Rises By 29.5% - Defense World
ICU Secures U.S. DoD Grant for Advanced Burn and Injury Research - GuruFocus
Military Selects SeaStar Medical from 160 Companies for Critical Burn Treatment Research Grant - Stock Titan
How SeaStar Medical Is Leveraging Its Breakthrough Medical Device Designation To Help Critically Ill Patients - MSN
SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market - Yahoo Finance
SeaStar Medical secures second CMS trial coverage By Investing.com - Investing.com South Africa
SeaStar Medical (ICU) Secures CMS Coverage for Clinical Trial Ex - GuruFocus
SeaStar Medical secures second CMS trial coverage - Investing.com
SeaStar Medical Wins Elite CMS Coverage Status: Only 100 Trials Get This Medicare Advantage - Stock Titan
SeaStar Medical Advances Organ-Saving Therapies for Critically Ill Patients - citybuzz -
SeaStar Medical (ICU) Announces Offering of Common Stock Shares | ICU Stock News - GuruFocus
Prediction: Rocket Lab USA Is Going Global - The Globe and Mail
Finanzdaten der Seastar Medical Holding Corp-Aktie (ICU)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):